(Q34580608)

English

Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Masakatsu Yanagimachi

1

1 reference

Europe PubMed Central

3 August 2017

Takuya Naruto

2

1 reference

Europe PubMed Central

3 August 2017

Takuma Hara

3

1 reference

Europe PubMed Central

3 August 2017

Masako Kikuchi

4

1 reference

Europe PubMed Central

3 August 2017

Ryoki Hara

5

1 reference

Europe PubMed Central

3 August 2017

Takako Miyamae

6

1 reference

Europe PubMed Central

3 August 2017

Tomoyuki Imagawa

7

1 reference

Europe PubMed Central

3 August 2017

Masaaki Mori

8

1 reference

Europe PubMed Central

3 August 2017

Tetsuji Kaneko

9

1 reference

Europe PubMed Central

3 August 2017

Satoshi Morita

10

1 reference

Europe PubMed Central

3 August 2017

Hiroaki Goto

11

1 reference

Europe PubMed Central

3 August 2017

Shumpei Yokota

12

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 February 2011

1 reference

Europe PubMed Central

3 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

3 August 2017

71

1 reference

Europe PubMed Central

3 August 2017

2

1 reference

Europe PubMed Central

3 August 2017

237-243

1 reference

Europe PubMed Central

3 August 2017

Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

Pharmacogenetic relevance of MTHFR polymorphisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

Outcome following onset of juvenile idiopathic inflammatory arthritis: II. predictors of outcome in juvenile arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

The International HapMap Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

7 July 2018

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03814.X

21 January 2018

Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03814.X

21 January 2018

Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

27 October 2018

Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040544

27 October 2018

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03814.X

21 January 2018

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2010.03814.X

21 January 2018

Pharmacokinetics, efficacy, and safety of short-term (12 weeks) etanercept for methotrexate-refractory polyarticular juvenile idiopathic arthritis in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/21219404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21219404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of low dose methotrexate therapy in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21219404

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2010.03814.X

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34580608&oldid=1620741601"